Literature DB >> 2266779

Mouse brain distribution of a carbon-11 labeled vesamicol derivative: presynaptic marker of cholinergic neurons.

M R Kilbourn1, Y W Jung, M S Haka, D L Gildersleeve, D E Kuhl, D M Wieland.   

Abstract

The regional mouse brain distribution of a new carbon-11 labeled derivative of vesamicol, [11C]-5-(N-methylamino)benzovesamicol [( 11C]MABV) is reported. Radiotracer concentrations in vivo are in the rank order of striatum greater than cortex greater than hippocampus greater than hypothalamus greater than cerebellum, consistent with reported distributions of other presynaptic cholinergic neuronal markers. In time course studies, striatum/cerebellum and cortex/cerebellum ratios for (-)-[11C]MABV continue to increase to values of 13 and 5, respectively, 75 min after i.v. injection of [11C]MABV. The specific binding in striatum and cortex is lowered by pretreatment with (+/-)-vesamicol, and shows stereoselectivity with lower uptake and lower ratios for the (+)-enantiomer. (-)-enantiomer. (-)-[11C]MABV is proposed as a positron-emitting radioligand for the in vivo study of presynaptic cholinergic neurons.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2266779     DOI: 10.1016/0024-3205(90)90408-j

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

Review 1.  Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology.

Authors:  G Stöcklin
Journal:  Eur J Nucl Med       Date:  1992

2.  5-tert-Butyl-2-(4'-[18F]fluoropropynylphenyl)-1,3-dithiane oxides: potential new GABA A receptor radioligands.

Authors:  Xuehe Li; Yong-Woon Jung; Scott E Snyder; Joseph Blair; Philip S Sherman; Timothy Desmond; Kirk A Frey; Michael R Kilbourn
Journal:  Nucl Med Biol       Date:  2007-11-26       Impact factor: 2.408

3.  Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice.

Authors:  Jen-Tzer Gau; Michelle L Steinhilb; Tzu-Cheg Kao; Constance J D'Amato; James R Gaut; Kirk A Frey; R Scott Turner
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

4.  Exploration of Sulfur-Containing Analogues for Imaging Vesicular Acetylcholine Transporter in the Brain.

Authors:  Zonghua Luo; Hui Liu; Hongjun Jin; Jiwei Gu; Yanbo Yu; Kota Kaneshige; Joel S Perlmutter; Stanley M Parsons; Zhude Tu
Journal:  ChemMedChem       Date:  2018-08-19       Impact factor: 3.466

5.  Characterization of [3H]vesamicol binding in rat brain preparations.

Authors:  E M Meyer; S O Bryant; R H Wang; R J Watson
Journal:  Neurochem Res       Date:  1993-10       Impact factor: 3.996

6.  Syntheses and radiosyntheses of two carbon-11 labeled potent and selective radioligands for imaging vesicular acetylcholine transporter.

Authors:  Prashanth K Padakanti; Xiang Zhang; Junfeng Li; Stanley M Parsons; Joel S Perlmutter; Zhude Tu
Journal:  Mol Imaging Biol       Date:  2014-12       Impact factor: 3.488

7.  Positron emission tomography imaging of (2R,3R)-5-[(18)F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter.

Authors:  Michael R Kilbourn; Brian Hockley; Lihsueh Lee; Phillip Sherman; Carole Quesada; Kirk A Frey; Robert A Koeppe
Journal:  Nucl Med Biol       Date:  2009-05-08       Impact factor: 2.408

Review 8.  In Vivo and In Vitro Characteristics of Radiolabeled Vesamicol Analogs as the Vesicular Acetylcholine Transporter Imaging Agents.

Authors:  Kazuma Ogawa; Kazuhiro Shiba
Journal:  Contrast Media Mol Imaging       Date:  2018-06-13       Impact factor: 3.161

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.